Connect Biopharma Holdings (CNTB) EBT (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted EBT of -$19.3 million for Q1 2026, down 28.3% sequentially from -$15.1 million in Q4 2025, and down 89.37% YoY from -$182.1 million in Q1 2025.
Connect Biopharma Holdings (CNTB) EBT (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported EBT for 3 years, with the latest figure at -$19.3 million in Q1 2026.
- Quarterly EBT fell 89.37% year-over-year to -$19.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$64.4 million (down 279.81% YoY) and the FY2025 annual result came in at -$55.3 million, down 258.86% from the prior year.
- EBT retreated to -$19.3 million in Q1 2026 per CNTB's latest filing, from -$15.1 million in the prior quarter.
- Over five years, EBT peaked at $14.9 million in Q2 2024 and troughed at -$19.3 million in Q1 2026.
- A 3-year average of -$10.0 million and a median of -$12.8 million in 2024 frame the typical range for EBT.
- The widest YoY moves for EBT: up 17.95% in 2025, down 186.33% in 2025.
- Over 3 years, EBT stood at -$8.8 million in 2024, then sank by 71.39% to -$15.1 million in 2025, then slipped by 28.3% to -$19.3 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$19.3 million, -$15.1 million, and -$17.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Connect Biopharma Holdings | 144.32 Mn | 144.32 Mn | - | -17.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.22 Mn |
| Mar 31, 2026 | -19.35 Mn |
| Dec 31, 2025 | -15.08 Mn |
| Sep 30, 2025 | -17.14 Mn |
| Jun 30, 2025 | -12.84 Mn |
| Mar 31, 2025 | -10.22 Mn |
| Dec 31, 2024 | -8.80 Mn |
| Sep 30, 2024 | -12.82 Mn |
| Jun 30, 2024 | 14.88 Mn |
| Mar 31, 2024 | -8.66 Mn |